The latest announcement is out from VSee Health ( (VSEE) ).

J.C. Penney Co Inc JCPNQ.PK said on Wednesday it has entered an asset purchase agreement with Brookfield Asset Management Inc , Simon Property Group and a majority of the company's first lien lenders.

On October 9, 2025, NovaBay Pharma entered into a Securities Purchase Agreement with R01 Fund LP and Framework Ventures IV L.P. to transfer shares of Series D and Series E Preferred Stock previously ...

TRAVERSE CITY – The Traverse City Commission will hold a meeting on Sept. 22 to discuss the authorization of a one-year extension of the purchase agreement for the city-owned property at 159 East ...

Company Increases Fiscal Year 2025 Revenue Guidance to Range of $14.5 million to $15.5 million Company Issues Preliminary Fiscal Year 2026 Pro Forma Revenue Guidance of $30 million to $35 Million; a ...

SINGAPORE, September 11, 2025--(BUSINESS WIRE)--With reference to the stock exchange announcement of 3 September 2025, Hafnia Limited ("Hafnia", the "Company", OSE ...

EQT Corporation EQT, a leading U.S.-based natural gas producer, has inked an agreement with Commonwealth LNG for the purchase of 1 million tons per annum (mtpa) of liquefied natural gas (LNG). The ...

Derrick LaPoint, president and CEO of Downtown Moorhead Inc., said the option agreement will allow DG Fuels to hold the land. DG Fuels is eyeing Moorhead land for a $5 billion facility. Derrick ...

BEIJING, Aug. 27, 2025 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technology and marketing ...

ADNOC has signed a 15-year sales and purchase agreement (SPA) with Indian Oil Corporation Ltd (IndianOil) for the supply of 1 million tonnes per annum (mtpa) of liquefied natural gas (LNG), sourced ...

VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Today, the British Columbia Utilities Commission (BCUC) accepted 10 energy purchase agreements between BC Hydro and proponents of its 2024 ...

Royalty Pharma to acquire rights to BeOne’s royalties on IMDELLTRA® (tarlatamab-dlle) worldwide (ex-China) sales for up to $950 million IMDELLTRA is a first-in-class DLL-3 targeting bispecific T-cell ...